Related Experiment Video
Updated: Jan 22, 2026

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
12th GCC Closed Forum: critical reagents; oligonucleotides; CoA; method transfer; HRMS; flow cytometry; regulatory
Chad Briscoe1, Nicola Hughes2, Roger Hayes3
1PRA Health Sciences, Lenexa, KS, USA.
Insights
The 12th GCC Closed Forum convened bioanalytical experts to address critical scientific and regulatory challenges in bioanalysis, including reagents, method transfer, and immunogenicity. Discussions yielded consensus on key issues impacting bioanalytical research and development.
Area of Science:
- Bioanalysis
- Pharmaceutical Sciences
- Regulatory Science
Background:
- The 12th GCC Closed Forum brought together international bioanalytical Contract Research Organizations.
- The forum focused on addressing pressing scientific and regulatory challenges within the field of bioanalysis.
Purpose of the Study:
- To discuss and reach consensus on key scientific and regulatory issues in bioanalysis.
- To share insights on critical reagents, oligonucleotides, certificates of analysis, method transfer, and advanced analytical techniques.
- To review recent regulatory findings and case studies related to stability and nonclinical immunogenicity.
Main Methods:
- Expert discussions and consensus-building among international bioanalytical Contract Research Organizations.
- Review of specific bioanalytical topics including critical reagents, oligonucleotides, and method transfer.
- Analysis of case studies concerning stability and nonclinical immunogenicity in regulatory contexts.
Main Results:
- Identification of key challenges and areas for improvement in bioanalytical practices.
- Consensus reached on best practices for critical reagents, method transfer, and data reporting.
- Insights gained into regulatory expectations for stability and nonclinical immunogenicity studies.
Conclusions:
- The forum facilitated a collaborative approach to resolving complex bioanalytical issues.
- Agreed-upon conclusions provide guidance for enhancing the quality and reliability of bioanalytical data.
- The discussions highlighted the importance of staying abreast of regulatory updates and scientific advancements in bioanalysis.
Abstract:
The 12th GCC Closed Forum was held in Philadelphia, PA, USA, on 9 April 2018. Representatives from international bioanalytical Contract Research Organizations were in attendance in order to discuss scientific and regulatory issues specific to bioanalysis. The issues discussed at the meeting included: critical reagents; oligonucleotides; certificates of analysis; method transfer; high resolution mass spectrometry; flow cytometry; recent regulatory findings and case studies involving stability and nonclinical immunogenicity. Conclusions and consensus from discussions of these topics are included in this article.
Related Concept Videos
Critical Numbers and the Closed Interval Method
Finding Critical Values for Chi-Square
Flow Cytometry
In...
Cis-regulatory Sequences
High-Resolution Mass Spectrometry (HRMS)
Nuclear Stability
To hold positively charged protons together...

